• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Compartmental models for apical efflux by P-glycoprotein: part 2--a theoretical study on transporter kinetic parameters.P-糖蛋白介导的顶端外排的房室模型:第2部分——转运体动力学参数的理论研究
Pharm Res. 2014 Feb;31(2):335-46. doi: 10.1007/s11095-013-1163-8.
2
Compartmental models for apical efflux by P-glycoprotein--part 1: evaluation of model complexity.P-糖蛋白介导的顶端外排的房室模型——第1部分:模型复杂性评估
Pharm Res. 2014 Feb;31(2):347-59. doi: 10.1007/s11095-013-1164-7. Epub 2013 Sep 10.
3
Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers.案例研究 8:P-糖蛋白介导的细胞单层共培养转运的结构批量作用动力学模型的状态。
Methods Mol Biol. 2021;2342:737-763. doi: 10.1007/978-1-0716-1554-6_27.
4
Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).利用过表达P-糖蛋白(Pgp)、多药耐药相关蛋白(MRP1)和小管多特异性有机阴离子转运体(cMOAT)的Madin-Darby犬肾(MDCK)细胞,描绘分泌性转运体在依托泊苷外排中的作用。
Drug Metab Dispos. 2002 Apr;30(4):457-63. doi: 10.1124/dmd.30.4.457.
5
Models to predict unbound intracellular drug concentrations in the presence of transporters.预测存在转运蛋白时未结合细胞内药物浓度的模型。
Drug Metab Dispos. 2012 May;40(5):865-76. doi: 10.1124/dmd.111.044289. Epub 2012 Jan 25.
6
Examining P-gp efflux kinetics guided by the BDDCS - Rational selection of in vitro assay designs and mathematical models.考察由 BDDCS 指导的 P-糖蛋白外排动力学:体外检测设计和数学模型的合理选择。
Eur J Pharm Sci. 2019 Apr 30;132:132-141. doi: 10.1016/j.ejps.2019.03.005. Epub 2019 Mar 9.
7
Extrapolation of Elementary Rate Constants of P-glycoprotein-Mediated Transport from MDCKII-hMDR1-NKI to Caco-2 Cells.P-糖蛋白介导的转运的基本速率常数从MDCKII-hMDR1-NKI细胞外推至Caco-2细胞
Drug Metab Dispos. 2017 Feb;45(2):190-197. doi: 10.1124/dmd.116.072140. Epub 2016 Nov 16.
8
The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems.基底外侧转运体在瑞舒伐他汀转运中的作用及其与顶端乳腺癌耐药蛋白在极化细胞单层系统中的相互作用。
Drug Metab Dispos. 2012 Nov;40(11):2102-8. doi: 10.1124/dmd.112.045666. Epub 2012 Aug 1.
9
Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.犬 P-糖蛋白缺陷型 MDCK II 细胞系的特征鉴定和验证及其在外排底物筛选中的应用。
Pharm Res. 2020 Sep 11;37(10):194. doi: 10.1007/s11095-020-02895-9.
10
Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.P-糖蛋白介导的分泌在药物吸收性通透性中的作用:一种利用被动膜通透性和对P-糖蛋白亲和力的方法。
J Pharm Sci. 1999 Oct;88(10):1067-72. doi: 10.1021/js980378j.

引用本文的文献

1
The Rat Continuous Intestine Model Predicts the Impact of Particle Size and Transporters on the Oral Absorption of Glyburide.大鼠连续肠道模型可预测粒径和转运体对格列本脲口服吸收的影响。
Mol Pharm. 2023 Jan 2;20(1):219-231. doi: 10.1021/acs.molpharmaceut.2c00597. Epub 2022 Dec 21.
2
A permeability- and perfusion-based PBPK model for improved prediction of concentration-time profiles.一种基于渗透和灌注的 PBPK 模型,可改善浓度-时间曲线的预测。
Clin Transl Sci. 2022 Aug;15(8):2035-2052. doi: 10.1111/cts.13314. Epub 2022 May 31.
3
Using partition analysis as a facile method to derive net clearances.使用分区分析作为一种简单的方法来推导净清除率。
Clin Transl Sci. 2022 Aug;15(8):1867-1879. doi: 10.1111/cts.13310. Epub 2022 Jun 2.
4
Prediction of Drug Clearance from Enzyme and Transporter Kinetics.预测药物清除率的酶和转运体动力学。
Methods Mol Biol. 2021;2342:369-417. doi: 10.1007/978-1-0716-1554-6_14.
5
Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.利用微粒体分配预测组织-血浆分配系数:纳入基于生理的药代动力学模型和稳态分布容积预测。
Drug Metab Dispos. 2019 Oct;47(10):1050-1060. doi: 10.1124/dmd.119.087973. Epub 2019 Jul 19.
6
Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.药物-转运体相互作用的分子建模——国际转运体联合会观点。
Clin Pharmacol Ther. 2018 Nov;104(5):818-835. doi: 10.1002/cpt.1174. Epub 2018 Aug 30.
7
Drug Distribution. Part 1. Models to Predict Membrane Partitioning.药物分布。第1部分。预测膜分配的模型。
Pharm Res. 2017 Mar;34(3):535-543. doi: 10.1007/s11095-016-2085-z. Epub 2016 Dec 15.
8
Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.存在代谢和转运情况下细胞内未结合的阿托伐他汀浓度
J Pharmacol Exp Ther. 2016 Oct;359(1):26-36. doi: 10.1124/jpet.116.235689. Epub 2016 Jul 22.
9
Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.开启健康与疾病状态下体内外推断入口的肾脏研究钥匙:第一部分:体外系统与生理数据。
AAPS J. 2016 Sep;18(5):1067-1081. doi: 10.1208/s12248-016-9942-x. Epub 2016 Jun 30.

本文引用的文献

1
Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.细胞内药物浓度和转运体:测量、建模及其对肝脏的影响。
Clin Pharmacol Ther. 2013 Jul;94(1):126-41. doi: 10.1038/clpt.2013.78. Epub 2013 Apr 10.
2
ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans.国际理论化学与应用化学联合会关于转运体动力学参数估算以及人类转运体介导的 PK 和 DDI 转化模型的建议。
Clin Pharmacol Ther. 2013 Jul;94(1):64-79. doi: 10.1038/clpt.2013.45. Epub 2013 Feb 25.
3
Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.线虫多药外排转运蛋白 P-糖蛋白的晶体结构
Nature. 2012 Oct 25;490(7421):566-9. doi: 10.1038/nature11448. Epub 2012 Sep 23.
4
Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics.述评:非特异性蛋白结合与膜分配:这不仅仅是语义学的问题。
Drug Metab Dispos. 2012 Sep;40(9):1649-52. doi: 10.1124/dmd.112.046599. Epub 2012 Jun 18.
5
Models to predict unbound intracellular drug concentrations in the presence of transporters.预测存在转运蛋白时未结合细胞内药物浓度的模型。
Drug Metab Dispos. 2012 May;40(5):865-76. doi: 10.1124/dmd.111.044289. Epub 2012 Jan 25.
6
Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model.同时评估大鼠肝细胞的摄取和代谢:一个全面的机制模型。
J Pharmacol Exp Ther. 2012 Apr;341(1):2-15. doi: 10.1124/jpet.111.187112. Epub 2011 Dec 21.
7
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.脑内游离药物暴露的测量:pH 分配模型解释了脑切片与脑匀浆方法之间差异结果的原因。
Drug Metab Dispos. 2011 Mar;39(3):353-62. doi: 10.1124/dmd.110.035998. Epub 2010 Dec 13.
8
Interplay of transporters and enzymes in the Caco-2 cell monolayer: I. effect of altered apical secretion.Caco-2 细胞单层中转运体和酶的相互作用:I. 顶分泌改变的影响。
Biopharm Drug Dispos. 2010 May;31(4):215-27. doi: 10.1002/bdd.704.
9
Membrane transporters in drug development.药物开发中的膜转运体。
Nat Rev Drug Discov. 2010 Mar;9(3):215-36. doi: 10.1038/nrd3028.
10
Model analysis of the concentration-dependent permeability of P-gp substrates.P-糖蛋白底物浓度依赖性渗透性的模型分析。
Pharm Res. 2010 Mar;27(3):442-6. doi: 10.1007/s11095-009-0026-9. Epub 2010 Feb 5.

P-糖蛋白介导的顶端外排的房室模型:第2部分——转运体动力学参数的理论研究

Compartmental models for apical efflux by P-glycoprotein: part 2--a theoretical study on transporter kinetic parameters.

作者信息

Korzekwa Ken, Nagar Swati

出版信息

Pharm Res. 2014 Feb;31(2):335-46. doi: 10.1007/s11095-013-1163-8.

DOI:10.1007/s11095-013-1163-8
PMID:23959852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3930629/
Abstract

PURPOSE

The impact of efflux transporters in intracellular concentrations of a drug can be predicted with modeling techniques. In Part 1, several compartmental models were developed and evaluated. The goal of Part 2 was to apply these models to the characterization and interpretation of saturation kinetic data.

METHODS

The compartmental models from Part 1 were used to evaluate a previously published dataset from cell lines expressing varying levels of P-glycoprotein. Kinetic parameters for the transporter were estimated and compared across models.

RESULTS

Fits and errors for all compartmental models were identical. All compartmental models predicted more consistent parameters than the Michaelis-Menten model. The 5-compartment model with efflux out of the membrane predicted differential impact of P-gp upon apical versus basolateral drug exposure. Finally, the saturable kinetics of active efflux along with a permeability barrier was modeled to delineate a relationship between intracellular concentration with or without active efflux versus donor concentration. This relationship was not a rectangular hyperbola, but instead was shown to be a quadratic function.

CONCLUSIONS

One approach to estimate an in vivo transporter effect is to first model an intracellular Km value from in vitro data, and use this value along with the appropriate tissue transporter expression levels and relative surface area to calculate the relevant apparent Km (or Ki) values. Together with the results from Part 1, these studies suggest that compartmental models can provide a path forward to better utilize in vitro transporter data for in vivo predictions such as physiologically based pharmacokinetic modeling.

摘要

目的

可以使用建模技术预测外排转运蛋白对药物细胞内浓度的影响。在第1部分中,开发并评估了几种房室模型。第2部分的目标是将这些模型应用于饱和动力学数据的表征和解释。

方法

使用第1部分中的房室模型评估先前发表的来自表达不同水平P-糖蛋白的细胞系的数据集。估计转运蛋白的动力学参数并在各模型之间进行比较。

结果

所有房室模型的拟合度和误差均相同。所有房室模型预测的参数比米氏模型更一致。具有膜外排的五房室模型预测了P-糖蛋白对顶端与基底外侧药物暴露的不同影响。最后,对主动外排的饱和动力学以及通透性屏障进行建模,以描绘有或无主动外排时细胞内浓度与供体浓度之间的关系。这种关系不是矩形双曲线,而是显示为二次函数。

结论

估计体内转运蛋白效应的一种方法是首先根据体外数据对细胞内Km值进行建模,并使用该值以及适当的组织转运蛋白表达水平和相对表面积来计算相关的表观Km(或Ki)值。与第1部分的结果一起,这些研究表明房室模型可以为更好地利用体外转运蛋白数据进行体内预测(如基于生理学的药代动力学建模)提供一条前进的道路。